There is great under-use of proven therapies for the secondary prevention of cardiovascular disease, according to results presented today from the PURE (Prospective Urban Rural Epidemiological) study.
"The study indicates a large gap in secondary prevention globally," said Dr Salim Yusuf, lead author and Executive Director of the Population Health Research Institute at McMaster University, Canada. "We found extremely low rates of use of proven therapies in all countries, but these were more marked in middle and low income countries."